| |
 |
GAZYVA |
גזייבה |
 |
|
 |
כן, יש ללחוץ כאן לפירוט |
בסל הבריאות?: |
|
 |
Chronic Lymphocytic Leukaemia (CLL)Gazyva, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic Leukaemia (CLL).Follicular Lymphoma (FL )Gazyva, in combination with bendamustine followed by Gazyva monotherapy, is indicated for the treatment of patients with follicular lymphoma (FL) who did not respond or who progressed during or up to 6 months after treatment with a rituximab-containing regimen.Gazyva in combination with chemotherapy, followed by Gazyva maintenance therapy in patients achieving a response, is indicated for the treatment of patients with previously untreated advanced follicular lymphoma. |
התוויה מאושרת: |
 |
CONCENTRATE FOR SOLUTION FOR INFUSION |
דרך מתן:
|
 |
ROCHE PHARMACEUTICALS (ISRAEL) LTD |
בעל רישום: |
 |
153-41-34195-00 |
מספר רישום:
|
 |
 |
רכיב פעיל |
כמות |
 |
OBINUTUZUMAB |
1000 MG / 40 ML |
 |
ATC description |
 |
MONOCLONAL ANTIBODIES |
 |
ATC-ניתן ללחוץ על קבוצת ה |
|
 |
 |
 |
 |
INFO ON THE WEB |
מידע ברשת |
 |
 |
 |
|
|